Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
distal myopathy with vocal cord weakness
Mode Of Inheritance:
Autosomal dominant
Evaluated Date:
10/08/2024
Evidence/Notes:

Variants in MATR3 were first reported as a cause of autosomal dominant distal myopathy with vocal cord weakness in 2009 (Senderek J, et al., 2009, PMID: 19344878). The MATR3 gene encodes matrin-3, a highly conserved nuclear matrix protein that binds and interacts with nucleic acids (Belgrader et al., 1991; Hibino et al., 2006). It plays a role in RNA transcription and processing, as well as mRNA stabilization (Hibino et al., 2006). Structurally, the protein includes two zinc finger domains that interact with DNA, along with two domains that bind RNA (Belgrader et al., 1991; Hibino et al., 2006; Salton et al., 2011; Johnson et al., 2014). Heterozygous variants in the MATR3 gene are asserted to casue amyotrophic lateral sclerosis (ALS) type 21 and distal myopathy with vocal cord and pharyngeal weakness (VCPDM) inherited in an autosomal dominant manner (Senderek et al., 2009; Johnson et al., 2014); the ALS GCEP has lumped these into a single curation for distal myopathy based on an overlap of phenotypes and molecular mechanism. Evidence supporting this gene-disease relationship includes case-level data, segregation data and experimental data. At least 12 missense variants have been reported in 20 probands from 17 publications (PMIDs: 24686783, 28029397, 26493020, 25771394, 26199109, 26708275, 31432357, 31475037, 19344878, 25154462, 25185957, 25952333, 32361838, 29628183, 34659085, 35812165, 39192891). The Ser85Cys variant is recurrent and predominantly found in patients with distal myopathy, however one family was retrospectively diagnose with ALS (PMID: 24686783). Segregation of this variant across 39 patients from 5 families was included in this curation. Experimentally, this gene-disease relationship is supported by the role of MATR3 as an RNA-binding protein involved in mRNA transport and nuclear export, processes known to be impacted in ALS (PMID: 29109432). Additionally, MATR3 has been found to bind and interact with critical ALS proteins TDP-43 (PMID: 24686783, 29109432), FUS (PMID: 29109432) and C9orf92 (PMID: 33129345). Further support is provided by a mouse models including overexpression and CRISPR-cas9 knock-in models (PMID: 33082323) that partially recapitulates phenotypic and pathological features. In summary, there is definitive evidence to support the relationship between MATR3 and autosomal dominant distal myopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.

PubMed IDs:
19344878 24686783 25154462 25185957 25771394 25952333 26199109 26493020 26708275 28029397 29109432 29628183 30015619 30563574 31432357 31475037 32028661 32361838 32731393 33082323 33129345 34659085 35812165 39192891
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.